10:21
2026-06-13
letsdatascience.com
artificial-intelligence
Cellular Intelligence Acquires Global Rights to STEM-PD
Cellular Intelligence, an AI-native biotech, acquired global rights to STEM-PD, a Phase 2-ready cell therapy for Parkinson's disease, from Novo Nordisk. Novo Nordisk shuttered its cell therapy unit in…